These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12507537)

  • 21. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
    Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
    BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.
    Hegde SS; Eglen RM
    Life Sci; 1999; 64(6-7):419-28. PubMed ID: 10069505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype.
    D'Agostino G; Bolognesi ML; Lucchelli A; Vicini D; Balestra B; Spelta V; Melchiorre C; Tonini M
    Br J Pharmacol; 2000 Feb; 129(3):493-500. PubMed ID: 10711347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit.
    Yokota T; Yamaguchi O
    J Urol; 1996 Nov; 156(5):1862-6. PubMed ID: 8863633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of methoctramine on bladder overactivity in a rat model.
    Ozturk H; Onen A; Guneli E; Cicek R; Tas Hekimoglu A
    Urology; 2003 Mar; 61(3):671-6. PubMed ID: 12639681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
    Abrams P; Andersson KE; Buccafusco JJ; Chapple C; de Groat WC; Fryer AD; Kay G; Laties A; Nathanson NM; Pasricha PJ; Wein AJ
    Br J Pharmacol; 2006 Jul; 148(5):565-78. PubMed ID: 16751797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cystometry in evaluating patients with overactive bladder.
    Flisser AJ; Blaivas JG
    Urology; 2002 Nov; 60(5 Suppl 1):33-42; discussion 42. PubMed ID: 12493350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic nervous control of the urinary bladder.
    Ochodnicky P; Uvelius B; Andersson KE; Michel MC
    Acta Physiol (Oxf); 2013 Jan; 207(1):16-33. PubMed ID: 23033838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction.
    Krichevsky VP; Pagala MK; Vaydovsky I; Damer V; Wise GJ
    J Urol; 1999 May; 161(5):1644-50. PubMed ID: 10210432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.
    Chess-Williams R
    Auton Autacoid Pharmacol; 2002 Jun; 22(3):133-45. PubMed ID: 12452898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic receptor subtypes and management of the overactive bladder.
    Chapple CR; Yamanishi T; Chess-Williams R
    Urology; 2002 Nov; 60(5 Suppl 1):82-8; discussion 88-9. PubMed ID: 12493364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
    BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The basis for drug treatment of the overactive bladder.
    Andersson KE; Chapple C; Wein A
    World J Urol; 2001 Nov; 19(5):294-8. PubMed ID: 11760776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [(3)H]-acetylcholine release experiments in the isolated detrusor.
    D' Agostino G; Maria Condino A; Calvi P
    Eur J Pharmacol; 2015 Jul; 758():115-22. PubMed ID: 25861936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
    Yamaguchi O
    Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder.
    Pagala MK; Tetsoti L; Nagpal D; Wise GJ
    J Urol; 2001 Aug; 166(2):721-7. PubMed ID: 11458124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study?
    Vecchioli-Scaldazza C; Grinta R
    Minerva Urol Nefrol; 2010 Dec; 62(4):355-61. PubMed ID: 20944536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity.
    Cerruto MA; Asimakopoulos AD; Artibani W; Del Popolo G; La Martina M; Carone R; Finazzi-Agrò E
    Urol Int; 2012; 89(1):1-8. PubMed ID: 22738896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the urinary bladder dysfunction in renovascular hypertensive rats.
    Ramos-Filho AC; Mónica FZ; Franco-Penteado CF; Rojas-Moscoso JA; Báu FR; Schenka AA; De Nucci G; Antunes E
    Neurourol Urodyn; 2011 Sep; 30(7):1392-402. PubMed ID: 21661033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.